1. Home /
  2. Biotechnology


Immatics Is a Bit Boy Who Cried Wolf

This is the type of chart that will grab the attention of momentum traders.

Want to Inject Some Growth Into Your Portfolio? Try This Dividend Stock

Pfizer is a quality dividend stock that's now trading at a discount.

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.

Compass Pathways Takes Investors on a Trip to Higher Prices

Fresh off IPO, company sees mushrooming opportunity in psilocybin.

Here Are 2 Small Biotech Names Where I'm Using My Simple Covered Call Strategy

Let's dig into Strongbridge Biopharma and Agenus.

Immatics Is a Biotech Where Patient Investors Could Be Handsomely Rewarded

2021 will be a big year, upside is at least twice the current valuation, and downside is limited to 10% from current levels.

Biotech M&A Picks Up: Lessons for Investors and Potential Targets

The euphoria in biotech stocks Monday was a nice change of pace. It also brought to the forefront some lessons about M&A in this industry.

Jim Cramer: Is This Market Undervalued?

Stocks are reasonable. Or even cheap. There will be more sell-offs ahead but remember this day and do not get too negative.

This Is Great Action for Stock Pickers Right Now

Stick to themes like biotechnology, SPACs, EV batteries, and others.

Spate of Deal News Juices Start of This Week's Trading

We've become accustomed lately to gap-up opens on Mondays, but some fresh acquisition agreements are helping drive this Monday's action.